Dr. John Buse, University of North Carolina School of Medicine (IMAGE)
Caption
Dr. John Buse of the University of North Carolina at Chapel Hill is co-principal investigator of the study, which is a follow-up to the ACCORD trial.
Credit
UNC School of Medicine
Usage Restrictions
None
License
Licensed content